Earnings Call · Q3 FY2022·2022-11-13

Q3 22EPS +7.69%·Rev n/aQ2 22EPS +22.22%·Rev n/aQ1 22EPS +17.24%·Rev n/aQ4 21EPS +6.67%·Rev n/a⚠ consensus missing

Trevi Therapeutics, Inc. TRVI

Jennifer Good — Chief Executive Officer

Lisa Delfini — Chief Financial Officer

+1.0%1d on move date+0.1% vs SPY3d+14.0%5d+10.9%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRVI calls or request research access.

More TRVI calls Browse calls Request research access